![Robert J. Garland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert J. Garland
Directeur/Membre du Conseil chez
Cardioxyl Pharmaceuticals LLC
Profil
Robert J.
Garland is currently a Director at Cardioxyl Pharmaceuticals LLC.
He previously worked as a Director at Novalar Pharmaceuticals, Inc., Zyngenia, Inc., Trevena, Inc., Sagimet Biosciences, Inc., Cleave Therapeutics, Inc., and Surface Oncology, Inc. He also worked as a Principal at McKinsey & Co., Inc. and a Venture Partner at NEA Management Co. LLC.
Garland received his undergraduate degree from Rice University, his graduate degree and MBA from the University of California, Berkeley, and his doctorate from Baylor College of Medicine.
Postes actifs de Robert J. Garland
| Sociétés | Poste | Début |
|---|---|---|
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Discovers and develops therapies and technologies for the treatment of cardiovascular diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert J. Garland
| Sociétés | Poste | Fin |
|---|---|---|
| SURFACE ONCOLOGY, INC. | Directeur/Membre du Conseil | - |
| SAGIMET BIOSCIENCES INC. | Directeur/Membre du Conseil | - |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Directeur/Membre du Conseil | - |
Novalar Pharmaceuticals, Inc.
 Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Directeur/Membre du Conseil | - |
Formation de Robert J. Garland
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Discovers and develops therapies and technologies for the treatment of cardiovascular diseases | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Choisissez Zonebourse 
